Live
RegulatoryFDA releases draft guidance on alternatives to animal testingDigitalNVIDIA and Lilly announce $1B AI co-innovation labTherapeuticMedVersa AI model matches specialists across imaging tasksOrganizationalLilly launches Employer Connect to expand obesity care accessCulturalCMS rule phases out fax machines, expected to save $782M yearlyCompetitiveMerck to acquire Terns Pharma for $6.7B in leukemia betDigitalOpenAI introduces GPT-5.4 with frontier coding capabilitiesOrganizationalZepbound KwikPen now available at self-pay pricing nationwideRegulatoryMedicare Part D out-of-pocket costs capped at $2,100 in 2026CulturalAlzheimer's Assoc. leads shift to early detection and preventionDigital57% of pharma now using AI to drive drug discoveryTherapeuticGenerative AI poised to restore physician-patient bondOrganizationalRetatrutide Phase 3: significant A1C and weight reductionsRegulatoryWhite House approves NIH's $48.7B FY2026 spending planCulturalRural patients drive 50+ miles one-way for neurology accessDigitalOpenAI acquires Promptfoo for AI evaluation and testingTherapeuticNIH: AI-powered tool could streamline chronic disease diagnosesOrganizationalLilly projects $80–83B revenue for 2026 on GLP-1 momentumRegulatoryFDA streamlines biosimilar development, could save $20M per drugDigitalRoche deploys 3,500+ NVIDIA GPUs for drug discovery AI factoryCompetitiveNovo Nordisk gains shot at better oral obesity drugs via VivtexOrganizationalLilly CMO: GLP-1 success brings societal obligation to do moreCulturalSenate reintroduces AADAPT Act to strengthen dementia workforceRegulatoryFTC launches Healthcare Task Force to protect patientsTherapeuticNEJM Catalyst: AI in healthcare moves from promise to practiceDigitalGTC 2026: agentic AI hits inflection point in life sciencesCulturalPart the Cloud grants $11M for innovative Alzheimer's treatmentsTherapeuticOsimertinib combo extends lung cancer survival to 47 monthsCompetitivePfizer Lyme vaccine cuts cases 73% but misses primary endpointRegulatoryFDA novel drug approvals tracker updated for 2026RegulatoryFDA releases draft guidance on alternatives to animal testingDigitalNVIDIA and Lilly announce $1B AI co-innovation labTherapeuticMedVersa AI model matches specialists across imaging tasksOrganizationalLilly launches Employer Connect to expand obesity care accessCulturalCMS rule phases out fax machines, expected to save $782M yearlyCompetitiveMerck to acquire Terns Pharma for $6.7B in leukemia betDigitalOpenAI introduces GPT-5.4 with frontier coding capabilitiesOrganizationalZepbound KwikPen now available at self-pay pricing nationwideRegulatoryMedicare Part D out-of-pocket costs capped at $2,100 in 2026CulturalAlzheimer's Assoc. leads shift to early detection and preventionDigital57% of pharma now using AI to drive drug discoveryTherapeuticGenerative AI poised to restore physician-patient bondOrganizationalRetatrutide Phase 3: significant A1C and weight reductionsRegulatoryWhite House approves NIH's $48.7B FY2026 spending planCulturalRural patients drive 50+ miles one-way for neurology accessDigitalOpenAI acquires Promptfoo for AI evaluation and testingTherapeuticNIH: AI-powered tool could streamline chronic disease diagnosesOrganizationalLilly projects $80–83B revenue for 2026 on GLP-1 momentumRegulatoryFDA streamlines biosimilar development, could save $20M per drugDigitalRoche deploys 3,500+ NVIDIA GPUs for drug discovery AI factoryCompetitiveNovo Nordisk gains shot at better oral obesity drugs via VivtexOrganizationalLilly CMO: GLP-1 success brings societal obligation to do moreCulturalSenate reintroduces AADAPT Act to strengthen dementia workforceRegulatoryFTC launches Healthcare Task Force to protect patientsTherapeuticNEJM Catalyst: AI in healthcare moves from promise to practiceDigitalGTC 2026: agentic AI hits inflection point in life sciencesCulturalPart the Cloud grants $11M for innovative Alzheimer's treatmentsTherapeuticOsimertinib combo extends lung cancer survival to 47 monthsCompetitivePfizer Lyme vaccine cuts cases 73% but misses primary endpointRegulatoryFDA novel drug approvals tracker updated for 2026

Healthcare intelligence

Design held to a standard of care

The engagement instrument for Eli Lilly Inc Lab.